Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 10.8 mg/ml (equivalent: folinic acid, qty 10 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - leucovorin calcium injection usp is indicated following high dose methotrexate therapy to reduce toxicity (leucovorin rescue). it is also indicated after inadvertent overdosage with methotrexate and in impaired methotrexate elimination.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 10.8 mg/ml (equivalent: folinic acid, qty 10 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride; hydrochloric acid - leucovorin calcium injection usp is indicated following high dose methotrexate therapy to reduce toxicity (leucovorin rescue). it is also indicated after inadvertent overdosage with methotrexate and in impaired methotrexate elimination.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - bupivacaine hydrochloride monohydrate, quantity: 105.4 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - bupivacaine injection is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia - epidural block for surgery - field block (minor and major nerve blocks and infiltration). analgesia - continuous epidural infusion or intermittent bolus epidural administration for analgesia in post operative pain or labour pain. - field block (minor nerve block amd infiltration). the choice of 2 strengths, 0.25% and 0.5%, makes it possible to vary the degree of motor blockade.

Australia - English - Department of Health (Therapeutic Goods Administration)

w l gore & associates (australia) pty ltd - 66383 - intravascular occluding/stent-graft post-dilation balloon catheter - a compliant polyurethane balloon is mounted on the leading end of a 3 lumen catheter shaft. termination of the leading end is an atraumatic catheter leading tip for smooth transition from the guidewire to catheter. radiopaque markers indicate the proximal and distal end of the balloon which aid in placement under fluoroscopy. both of the lumens facilitate balloon catheter preparation, inflation and deflation. at the trailing end is a dual port y-arm which allows for over-the-wire access. the gore? molding and occlusion balloon catheter (mob) is intended to serve as a balloon catheter accessory device. ballooning of a stent graft may improve molding of the graft material and fixation of the stent graft to the vessel wall. balloon occlusion of a large diameter vessel may provide hemostasis until vessel repair may be achieved.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - pyraclostrobin - emulsifiable concentrate - pyraclostrobin carbamate-methoxy active 250.0 g/l - fungicide

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - pethidine hydrochloride, quantity: 50 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - indications as at 18 may 2020: 1. the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. 2. pre-operative medication. 3. analgesic adjunct in general anaesthesia. 4. obstetric analgesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 36259 - prosthesis, internal, joint, shoulder, glenoid component - a component of the tornier perform reversed glenoid system intended to be threaded through the central post of the baseplates to provide primary fixation of the baseplate to the bone. the central screws are made of titanium alloy. a component of the tornier perform reversed glenoid system intended for replacement of the glenoid part of the scapulohumeral joint as part of a reverse shoulder prosthesis. the system is intended to reduce pain and improve shoulder mobility, in comparison with preoperative status, in patients with a functional deltoid muscle and with a massive and non-repairable rotator cuff-tear.

Australia - English - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 48091 - reverse shoulder prosthesis base plate - a component of the tornier perform reversed augmented glenoid system intended to be attached to the scapula to serve as the foundation of the glenosphere. made of titanium alloy. the backside of the baseplate has a porous structure and the topside is solid. the center post of the baseplate accommodates a central screw for primary fixation and up to four peripheral screws for additional stability. the baseplate comes in different augment wedge angles to accommodate glenoid bone loss. a component of the tornier perform reversed augmented glenoid system intended for replacement of the glenoid part of the scapulohumeral joint as part of a reverse shoulder prosthesis. the system is intended to reduce pain and improve shoulder mobility, in comparison with preoperative status, in patients with a functional deltoid muscle and with a massive and non-repairable rotator cuff-tear.

Australia - English - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 36259 - prosthesis, internal, joint, shoulder, glenoid component - a component of the tornier perform reversed glenoid system intended to be attached to the central post of the baseplate via locking threads to provide primary fixation of the baseplate to the bone. the press-fit post is made of of titanium alloy. a component of the tornier perform reversed glenoid system intended for replacement of the glenoid part of the scapulohumeral joint as part of a reverse shoulder prosthesis. the system is intended to reduce pain and improve shoulder mobility, in comparison with preoperative status, in patients with a functional deltoid muscle and with a massive and non-repairable rotator cuff-tear.

Australia - English - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 48091 - reverse shoulder prosthesis base plate - a component of the toriner perform reversed system intended to be attached to the scapula to serve as the foundation of the glenosphere. the baseplate is made of a single piece of titanium alloy. the backside of the baseplate has a porous structure and the topside of the baseplate is solid. the center post of the baseplate accommodates a central screw or a press-fit post for primary fixation to the bone, and up to four peripheral screws for additional stability. a component of the tornier perform reversed glenoid system intended for replacement of the glenoid part of the scapulohumeral joint as part of a reverse shoulder prosthesis. the system is intended to reduce pain and improve shoulder mobility, in comparison with preoperative status, in patients with a functional deltoid muscle and with a massive and non-repairable rotator cuff-tear.